<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1726-8958</journal-id>
<journal-title><![CDATA[Revista Médica La Paz]]></journal-title>
<abbrev-journal-title><![CDATA[Rev. Méd. La Paz]]></abbrev-journal-title>
<issn>1726-8958</issn>
<publisher>
<publisher-name><![CDATA[Colegio Médico de La Paz]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1726-89582024000300025</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[OXIGENOTERAPIA CON CÁNULA NASAL DE ALTO FLUJO EN INSUFICIENCIA RESPIRATORIA AGUDA POR COVID-19]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Ibáñez-Velasco]]></surname>
<given-names><![CDATA[Bismarck Raúl]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Aguirre Flores]]></surname>
<given-names><![CDATA[Danitza]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[García Choque]]></surname>
<given-names><![CDATA[Marco Antonio]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Aguirre Flores]]></surname>
<given-names><![CDATA[Mabel]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af4">
<institution><![CDATA[,Hospital Municipal La Portada Unidad de Terapia Intensiva Medico Intensivista]]></institution>
<addr-line><![CDATA[La Paz ]]></addr-line>
<country>Bolivia</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Hospital Municipal La Portada Area Clinica Medico Internista]]></institution>
<addr-line><![CDATA[La Paz ]]></addr-line>
<country>Bolivia</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Instituto Nacional de Torax Medico Neumologo Intervencionista ]]></institution>
<addr-line><![CDATA[La Paz ]]></addr-line>
<country>Bolivia</country>
</aff>
<aff id="Af1">
<institution><![CDATA[,Hospital Policial Potosi Medico de Guardia ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Bolivia</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>00</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>00</month>
<year>2024</year>
</pub-date>
<volume>30</volume>
<numero>3</numero>
<fpage>25</fpage>
<lpage>33</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.bo/scielo.php?script=sci_arttext&amp;pid=S1726-89582024000300025&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.bo/scielo.php?script=sci_abstract&amp;pid=S1726-89582024000300025&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.bo/scielo.php?script=sci_pdf&amp;pid=S1726-89582024000300025&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN  Objetivo:  Analizar el impacto clínico con el uso temprano de Oxigenoterapia con Cánula Nasal de Alto Flujo (CNAF), en pacientes con insuficiencia respiratoria aguda por COVID-19, sin indicación de Intubación inmediata.  Materiales y métodos: Estudio descriptivo, observacional y prospectivo..  Resultados: De 87 pacientes ingresados a UTI con Insuficiencia Respiratoria por COVID-19, 19 casos cumplen criterios de inclusión, masculino 57,89%(n=11) y femenino 42.1%( n=8), edad 34,8 (±6.6) años, afectación pulmonar medido por escala (CO-RADS) con predominio de categoría 3 en 42.1% (n=8), categoría 2 en 21.05% (n=4), indicación para inicio de oxigenoterapia por CNAF fue por SDRA Leve/Moderado 73.6% (n=14), SDRA Severo con Neumonía Severa por COVID-19 de 26.3% (n=5), El tiempo de uso de la CNAF fue de 96 h (±28), con estancia en UTI de 12 (±2) días y estancia hospitalaria 13 (±1), evaluando mejora respiratoria, corroborada (ÍNDICE de ROX (iROX), valor de fracaso &#8804; 2.75) registrándose un i-ROX: 3.42 (±1,2) inicial, y elevación hasta 5.8 (±0.9) (p = 0.05) a 72h en 15 pacientes (78.9%); registrando fracaso en 4 (21.1%) con soporte CNAF obteniendo i-ROX 2.2 a las 12h procediendo a ser intubados entre 24 h a 72 h. Demostrando el aumento significativo del (í-ROX), de mejora del trabajo respiratorio en 78.9% (n=15) vs fracaso del dispositivo CNAF en 4 que fueron intubados 21.1% (n=4), llegando a fallecer.  Conclusión: El uso temprano del dispositivo CNAF en neumonías por COVID-19 con Insufiencia respiratorio leve y moderado, resultaría una alternativa útil y beneficiosa como una terapéutica alternativa inicial.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[ABSTRACT  Objective: To analyze the clinical impact with the early use of Oxygen Therapy with High Flow Nasal Cannula (HFNC), in patients with acute respiratory failure due to COVID-19, without indication for immediate Intubation.  Materials and methods: Descriptive, observational and prospective study.  Results: Of 87 patients admitted to the ICU with Respiratory Failure due to COVID-19, 19 cases met inclusion criteria, male 57.89% (n=11) and female 42.1% (n=8), age 34.8 (±6.6). ) years, lung involvement measured by scale (CO-RADS) with a predominance of category 3 in 42.1% (n=8), category 2 in 21.05% (n=4), indication for initiation of oxygen therapy by HFNC was due to Mild ARDS/ Moderate 73.6% (n=14), Severe ARDS with Severe Pneumonia due to COVID-19 26.3% (n=5), The time of use of HFNC was 96 h (±28), with a stay in the ICU of 12 ( ±2) days and hospital stay 13 (±1), evaluating respiratory improvement, corroborated (ROX INDEX (iROX), failure value &#8804; 2.75) recording an i-ROX: 3.42 (±1.2) initial, and elevation up to 5.8 (±0.9) (p = 0.05) at 72h in 15 patients (78.9%); recording failure in 4 (21.1%) with CNAF support, obtaining i-ROX 2.2 at 12 hours, proceeding to be intubated between 24 hours and 72 hours. Demonstrating the signíficant increase in (í-ROX), improvement in respiratory work in 78.9% (n=15) vs failure of the HFNC device in 4 who were intubated 21.1% (n=4), leading to death.  Conclusión: The early use of the HFNC device in COVID-19 pneumonia with mild and moderate respiratory failure would be a useful and beneficial alternative as an initial alternative therapy.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Cánula Nasal de Alto Flujo]]></kwd>
<kwd lng="es"><![CDATA[Insuficiencia Respiratoria Aguda]]></kwd>
<kwd lng="es"><![CDATA[Sindrome de Distres Respiratorio Agudo]]></kwd>
<kwd lng="es"><![CDATA[Índice de ROX]]></kwd>
<kwd lng="es"><![CDATA[Ventilación No Invasiva]]></kwd>
<kwd lng="es"><![CDATA[CORADS]]></kwd>
<kwd lng="en"><![CDATA[High Flow Nasal Cannula]]></kwd>
<kwd lng="en"><![CDATA[Acute Respiratory Failure]]></kwd>
<kwd lng="en"><![CDATA[Acute Respiratory Distress Syndrome]]></kwd>
<kwd lng="en"><![CDATA[ROX Index]]></kwd>
<kwd lng="en"><![CDATA[Non-Invasive Ventilation]]></kwd>
<kwd lng="en"><![CDATA[CORADS]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Maggiore]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
<name>
<surname><![CDATA[Roca]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Salvatore]]></surname>
<given-names><![CDATA[O.]]></given-names>
</name>
<name>
<surname><![CDATA[Elena]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Bhakti]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Arnaud]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Non-invasive ventilator support and high-flow nasal oxygen as first-line treatment of acute hypoxemic respiratory failure and ARDS Springer-Verlag]]></article-title>
<source><![CDATA[Eur Respir J]]></source>
<year>2021</year>
<page-range>301-23</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kress]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Mancebo]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[j]]></surname>
<given-names><![CDATA[Antonelli]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[American Association for Respiratory Care (AARC) Clinical Practice Guideline. Oxygen therapy for adults in the acute care facility]]></article-title>
<source><![CDATA[Respir Care]]></source>
<year>2002</year>
<volume>47</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>717-20</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Roca]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Riera]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Torres]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Masclans]]></surname>
<given-names><![CDATA[JR]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[High-flow Oxygen Therapy in Acute Respiratory Failure]]></article-title>
<source><![CDATA[Respir Care]]></source>
<year>2010</year>
<volume>55</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>408-13</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pachón]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Navas]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Movimiento costal paradójico durante la inspiración (signo de Hoover) en pacientes hospitalizados por disnea]]></article-title>
<source><![CDATA[Revista Clínica Española]]></source>
<year>2005</year>
<volume>205</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>86-104</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lisha]]></surname>
<given-names><![CDATA[Zhang]]></given-names>
</name>
<name>
<surname><![CDATA[Rey]]></surname>
<given-names><![CDATA[Yuxiu]]></given-names>
</name>
<name>
<surname><![CDATA[Yaokun]]></surname>
<given-names><![CDATA[Ye]]></given-names>
</name>
<name>
<surname><![CDATA[Gao]]></surname>
<given-names><![CDATA[Yin]]></given-names>
</name>
<name>
<surname><![CDATA[Fabei]]></surname>
<given-names><![CDATA[Zhu]]></given-names>
</name>
<name>
<surname><![CDATA[Lingfeng]]></surname>
<given-names><![CDATA[Min]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Comparación de la cánula nasal de alto flujo con la oxigenoterapia convencional en pacientes con enfermedad pulmonary obstructiva crónica hipercápnica: una revisión sistemática y un metanálisis]]></article-title>
<source><![CDATA[Colección electrónica]]></source>
<year>2023</year>
<volume>18</volume>
<page-range>895-906</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Brusasco]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Corradi]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Di Domenico]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Demesion]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Continuous positive airway pressure in COVID-19 patients with moderate-to-severe respiratory failure]]></article-title>
<source><![CDATA[Eur Respir]]></source>
<year>2021</year>
</nlm-citation>
</ref>
<ref id="B7">
<label>7.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Zhang]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[lin]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Konghan]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[High-flow nasal cannula therapy for adult patients]]></article-title>
<source><![CDATA[J Int Med Res]]></source>
<year>2016</year>
<volume>44</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>1200-11</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sztrymf]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Messika]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Mayot]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Impact of high-flow nasal cannula oxygen therapy on intensive care unit patients with acute respiratory failure A prospective observational study]]></article-title>
<source><![CDATA[J Crit Care]]></source>
<year>2012</year>
<volume>27</volume>
<page-range>324-53</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Frizzola]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Miller]]></surname>
<given-names><![CDATA[TL]]></given-names>
</name>
<name>
<surname><![CDATA[Rodriguez]]></surname>
<given-names><![CDATA[ME]]></given-names>
</name>
<name>
<surname><![CDATA[Zhu]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Rojas]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[High-flow nasal cannula impact on oxygenation and ventilation in an acute lung injury model]]></article-title>
<source><![CDATA[Pediatr Pulmonol]]></source>
<year>2011</year>
<volume>46</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>67-74</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10.</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nishimura]]></surname>
<given-names><![CDATA[Masaji]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[High-Flow Nasal Cannula Oxygen Therapy in Adults: Physiological Benefits, Indication, Clinical Benefits, and Adverse effects respiratory care]]></article-title>
<source><![CDATA[]]></source>
<year>2016</year>
<volume>61</volume>
<numero>4</numero>
<issue>4</issue>
</nlm-citation>
</ref>
<ref id="B11">
<label>11.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[González]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Utilización del índice de ROX en la valoración del éxito de oxigenoterapia de alto flujo en la hipoxemia secundaria a coronavirus tipo 2]]></article-title>
<source><![CDATA[Medicina intensiva, j.medin]]></source>
<year>2021</year>
</nlm-citation>
</ref>
<ref id="B12">
<label>12.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[L'Her]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Deye]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Lellouche]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Physiologic effects of non invasive ventilation during acute lung injury]]></article-title>
<source><![CDATA[Am J Respir Crit Care Med]]></source>
<year>2005</year>
<volume>172</volume>
<page-range>1112-8</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Shoemaker]]></surname>
<given-names><![CDATA[MT]]></given-names>
</name>
<name>
<surname><![CDATA[Pierce]]></surname>
<given-names><![CDATA[MR]]></given-names>
</name>
<name>
<surname><![CDATA[Yoder]]></surname>
<given-names><![CDATA[BA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[High flow nasal cannula versus nasal CPAP for neonatal respiratory disease a retrospective study]]></article-title>
<source><![CDATA[J Perinatol]]></source>
<year>2007</year>
<volume>27</volume>
<page-range>85-91</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dani]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Pratesi]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Migliori]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[High flow nasal cannula therapy as respiratory support in the preterm infant]]></article-title>
<source><![CDATA[Pediatr Pulmonol]]></source>
<year>2009</year>
<volume>44</volume>
<page-range>629-34</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Roca]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Riera]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Torres]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[High-flow oxygen therapy in acute respiratory failure]]></article-title>
<source><![CDATA[Respir Care]]></source>
<year>2010</year>
<volume>55</volume>
<page-range>408-13</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Shepard Jr]]></surname>
<given-names><![CDATA[JW]]></given-names>
</name>
<name>
<surname><![CDATA[Burger]]></surname>
<given-names><![CDATA[CD]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Nasal and oral flow-volume loops in normal subjects and patients with obstructive sleep apnea]]></article-title>
<source><![CDATA[Am Rev Respir Dis]]></source>
<year>1990</year>
<volume>142</volume>
<page-range>1288-93</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Groves]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Tobin]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[High flow nasal oxygen generates positive airway pressure in adult volunteers]]></article-title>
<source><![CDATA[Aust Crit Care]]></source>
<year>2007</year>
<volume>20</volume>
<page-range>126-31</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Parke]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[McGuinness]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Eccleston]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Nasal high-flow therapy delivers low level positive airway pressure]]></article-title>
<source><![CDATA[Br J Anaesth]]></source>
<year>2009</year>
<volume>103</volume>
<page-range>886-90</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chatila]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Nugent]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Vance]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The effects of high-flow vs lowflow oxygen on exercise in advanced obstructive airways disease]]></article-title>
<source><![CDATA[Chest]]></source>
<year>2004</year>
<volume>126</volume>
<page-range>1108-15</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Demoule]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Girou]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Richard]]></surname>
<given-names><![CDATA[JC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Increased use of noninvasive ventilation in French intensive care units]]></article-title>
<source><![CDATA[Intensive Care Med]]></source>
<year>2006</year>
<volume>32</volume>
<page-range>1747-55</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Boyer]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Vargas]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Delacre]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prognostic impact of high-flow nasal cannula oxygen supply in an ICU patient with pulmonary fibrosis complicated by acute respiratory failure]]></article-title>
<source><![CDATA[Intensive Care Med]]></source>
<year>2011</year>
<volume>37</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>558-9</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22.</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Monro-Somerville]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Sim]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Ruddy]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Vilas]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Gillies]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
</person-group>
<source><![CDATA[The Effect of High-Flow Nasal Cannula Oxygen]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B23">
<label>23.</label><nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Therapy on Mortality and Intubation Rate in Acute Respiratory Failure: A Systematic Review and Meta-Analysis]]></article-title>
<source><![CDATA[Crit Care Med]]></source>
<year>2017</year>
<volume>45</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>e449-56</page-range></nlm-citation>
</ref>
<ref id="B24">
<label>24.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Frat]]></surname>
<given-names><![CDATA[JP]]></given-names>
</name>
<name>
<surname><![CDATA[Brugiere]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Ragot]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Sequential application of oxygen therapy via high-flow nasal cannula and noninvasive ventilation in acute respiratory failure an observational pilot study]]></article-title>
<source><![CDATA[Respir Care]]></source>
<year>2015</year>
<volume>60</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>170</page-range></nlm-citation>
</ref>
<ref id="B25">
<label>25.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Roca]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Caralt]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Messika]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[An Index Combining Respiratory Rate and Oxygenation to Predict Outcome of Nasal High-Flow Therapy]]></article-title>
<source><![CDATA[Am J Respir Crit Care Med]]></source>
<year>2019</year>
<volume>199</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>1368-76</page-range></nlm-citation>
</ref>
<ref id="B26">
<label>26.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Roca]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Messika]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Caralt]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Predicting success of high-flow nasal cannula in pneumonia patients with hypoxemic respiratory failure The utility of the ROX index]]></article-title>
<source><![CDATA[J Crit Care]]></source>
<year>2016</year>
<volume>35</volume>
<page-range>200-5</page-range></nlm-citation>
</ref>
<ref id="B27">
<label>27.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Parke]]></surname>
<given-names><![CDATA[RL]]></given-names>
</name>
<name>
<surname><![CDATA[McGuinness]]></surname>
<given-names><![CDATA[SP]]></given-names>
</name>
<name>
<surname><![CDATA[Eccleston]]></surname>
<given-names><![CDATA[ML]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A Preliminary Randomized Controlled Trial to Assess Effectiveness of Nasal High-Flow Oxygen in Intensive Care Patients]]></article-title>
<source><![CDATA[Respir Care]]></source>
<year>2011</year>
<volume>56</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>265-70</page-range></nlm-citation>
</ref>
<ref id="B28">
<label>28.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wu]]></surname>
<given-names><![CDATA[Z.]]></given-names>
</name>
<name>
<surname><![CDATA[McGoogan]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China]]></article-title>
<source><![CDATA[JAMA]]></source>
<year>2020</year>
<volume>323</volume>
<numero>13</numero>
<issue>13</issue>
</nlm-citation>
</ref>
<ref id="B29">
<label>29.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Demelo]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Olmedo]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Gaitán]]></surname>
<given-names><![CDATA[DG]]></given-names>
</name>
<name>
<surname><![CDATA[Cano]]></surname>
<given-names><![CDATA[JC]]></given-names>
</name>
<name>
<surname><![CDATA[Andueza Lillo]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Oxigenoterapia de alto flujo con cánula nasal: estudio preliminar en pacientes hospitalizados]]></article-title>
<source><![CDATA[Arch Bronconeumol]]></source>
<year>2015</year>
<volume>51</volume>
<numero>12</numero>
<issue>12</issue>
<page-range>657-9</page-range></nlm-citation>
</ref>
<ref id="B30">
<label>30.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gaunt]]></surname>
<given-names><![CDATA[KA]]></given-names>
</name>
<name>
<surname><![CDATA[Spilman]]></surname>
<given-names><![CDATA[SK]]></given-names>
</name>
<name>
<surname><![CDATA[Halub]]></surname>
<given-names><![CDATA[ME]]></given-names>
</name>
<name>
<surname><![CDATA[Jackson]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Lamb]]></surname>
<given-names><![CDATA[KD]]></given-names>
</name>
<name>
<surname><![CDATA[Sahr]]></surname>
<given-names><![CDATA[SM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[High-flow nasal cannula in a mixed adult ICU]]></article-title>
<source><![CDATA[Respir Care]]></source>
<year>2015</year>
<volume>60</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>1383-9</page-range></nlm-citation>
</ref>
<ref id="B31">
<label>31.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Zhu]]></surname>
<given-names><![CDATA[Z]]></given-names>
</name>
<name>
<surname><![CDATA[Liu]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[Q]]></given-names>
</name>
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Preliminary evaluation of sequential therapy by high flow nasal cannula oxygen therapy following endotracheal tube extubation in mechanically ventilated patients]]></article-title>
<source><![CDATA[Crit Care Med]]></source>
<year>2017</year>
<volume>29</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>778-82</page-range></nlm-citation>
</ref>
<ref id="B32">
<label>32.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sztrymf]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Messika]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Bertrand]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Hurel]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Leon]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Dreyfuss]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Beneficial effects of humidified high flow nasal oxygen in critical care patients: a prospective pilot study]]></article-title>
<source><![CDATA[Intensive Care Med]]></source>
<year>2011</year>
<volume>37</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>1780-6</page-range></nlm-citation>
</ref>
<ref id="B33">
<label>33.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Aguirre]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Ibañez]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Verduguez]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Villegas]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Uso de Cánula Nasal de Alto Flujo artisanal como Oxigenoterapia en insuficiencia respiratoria por covid-19]]></article-title>
<source><![CDATA[Revista "Cuadernos"]]></source>
<year>2023</year>
<volume>64</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>62-6</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
